Literature DB >> 3237312

Long-lasting changes in regional brain amino acids and monoamines in recovered pyrithiamine treated rats.

P J Langlais1, R G Mair, C D Anderson, W J McEntee.   

Abstract

Rats were subjected to a severe bout of thiamine deficiency induced by daily pyrithiamine + a thiamine deficient diet, reversed by thiamine administration and allowed to recover. Pyrithiamine treated animals demonstrated impaired retention of a 24 h recall of passive avoidance. Regional brain concentration of norepinephrine, dopamine, serotonin, 3,4-dihydroxyphenylacetic acid, 5-hydroxyindoleacetic acid, GABA, glutamate, aspartate, glutamine, and glycine were determined after 2 and 9 weeks of nutritional recovery. A significant increase in NE content of cerebellum from the pyrithiamine treated animals was observed at both 2 and 9 week recovery periods. The concentrations of serotonin and its metabolite were significantly elevated in midbrain-thalamus and striatum. Significant reductions of GABA and glutamate were also observed in midbrain-thalamus. Amino acid levels in all other brain areas were unchanged from pair-fed controls. These results suggest regionally specific, chronic alterations in GABA, glutamate, serotonin, and norepinephrine activity following recovery from an acute bout of pyrithiamine-induced thiamine deficiency. The absence of a permanent reduction of cortical norepinephrine similar to that observed in an earlier study is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3237312     DOI: 10.1007/bf00971639

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  Uptake of pyrithiamine by tissue of rats.

Authors:  G RINDI; V PERRI
Journal:  Biochem J       Date:  1961-07       Impact factor: 3.857

2.  Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy: 1. The pyruvate dehydrogenase complex.

Authors:  R F Butterworth; J F Giguere; A M Besnard
Journal:  Neurochem Res       Date:  1985-10       Impact factor: 3.996

3.  Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal.

Authors:  G E Gibson; H Ksiezak-Reding; K F Sheu; V Mykytyn; J P Blass
Journal:  Neurochem Res       Date:  1984-06       Impact factor: 3.996

4.  Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection.

Authors:  D W Ellison; M F Beal; J B Martin
Journal:  J Neurosci Methods       Date:  1987-04       Impact factor: 2.390

5.  Behavioral impairments, brain lesions and monoaminergic activity in the rat following recovery from a bout of thiamine deficiency.

Authors:  R G Mair; C D Anderson; P J Langlais; W J McEntee
Journal:  Behav Brain Res       Date:  1988-03       Impact factor: 3.332

6.  Alterations in uptake and metabolism of aspartate and glutamate in brain of thiamine deficient animals.

Authors:  A Plaitakis; W J Nicklas; S Berl
Journal:  Brain Res       Date:  1979-08-10       Impact factor: 3.252

7.  GABA neurons are the major cell type of the nucleus reticularis thalami.

Authors:  C R Houser; J E Vaughn; R P Barber; E Roberts
Journal:  Brain Res       Date:  1980-11-03       Impact factor: 3.252

8.  Model of Wernicke's encephalopathy.

Authors:  J C Troncoso; M V Johnston; K M Hess; J W Griffin; D L Price
Journal:  Arch Neurol       Date:  1981-06

9.  The effect of inhibition of hexosemonophosphate shunt on the metabolism of glucose and function in rat brain in vivo.

Authors:  M K Gaitonde; G M Evans
Journal:  Neurochem Res       Date:  1982-09       Impact factor: 3.996

10.  Brain mitochondrial metabolism in experimental thiamine deficiency.

Authors:  W D Parker; R Haas; D A Stumpf; J Parks; L A Eguren; C Jackson
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910

View more
  9 in total

1.  Cortical cholinergic abnormalities contribute to the amnesic state induced by pyrithiamine-induced thiamine deficiency in the rat.

Authors:  Steven Anzalone; Ryan P Vetreno; Raddy L Ramos; Lisa M Savage
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

Review 2.  Neuropathology of thiamine deficiency: an update on the comparative analysis of human disorders and experimental models.

Authors:  P J Langlais; S X Zhang; L M Savage
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

3.  A quantitative autoradiographic study of muscarinic cholinergic receptor subtypes in the brains of pyrithiamine-treated rats.

Authors:  V L Rao; D D Mousseau; R F Butterworth
Journal:  Neurochem Res       Date:  1995-08       Impact factor: 3.996

Review 4.  Brain and behavioral pathology in an animal model of Wernicke's encephalopathy and Wernicke-Korsakoff Syndrome.

Authors:  Ryan P Vetreno; Raddy L Ramos; Steven Anzalone; Lisa M Savage
Journal:  Brain Res       Date:  2011-11-28       Impact factor: 3.252

5.  Glucose loading precipitates acute encephalopathy in thiamin-deficient rats.

Authors:  C Zimitat; P F Nixon
Journal:  Metab Brain Dis       Date:  1999-03       Impact factor: 3.584

Review 6.  Glutamate: its role in learning, memory, and the aging brain.

Authors:  W J McEntee; T H Crook
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Levels, uptake, and release of glycine and glutamate in the rat pontine reticular formation.

Authors:  I Camacho-Arroyo; R Tapia
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

8.  Blocking GABA-A receptors in the medial septum enhances hippocampal acetylcholine release and behavior in a rat model of diencephalic amnesia.

Authors:  Jessica J Roland; Lisa M Savage
Journal:  Pharmacol Biochem Behav       Date:  2009-02-01       Impact factor: 3.533

Review 9.  Midline Thalamic Damage Associated with Alcohol-Use Disorders: Disruption of Distinct Thalamocortical Pathways and Function.

Authors:  Lisa M Savage; Polliana T Nunes; Zachary H Gursky; Katrina A Milbocker; Anna Y Klintsova
Journal:  Neuropsychol Rev       Date:  2020-08-12       Impact factor: 7.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.